DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Venus Remedies Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·9 Oct 2026, 5:55 am

Venus Remedies

Venus Remedies Limited has informed stock exchanges that it has received a certificate under SEBI's regulations for depositories and participants. This document confirms that the company has complied with the necessary rules regarding the maintenance of its securities with depositories.

For investors, this news is a routine regulatory update. It confirms that the company's shareholding structure is being maintained correctly with the depositories. This transparency is a standard requirement for listed entities and generally does not impact the company's core business operations or financial performance.

Investors should treat this as a standard compliance filing. There are no immediate market-moving implications, but keeping an eye on future regulatory filings remains a good practice for monitoring the company's corporate governance status.